Catalent plans capacity expansions at two biologics facilities
Catalent is planning to add capacity at two of its biologics manufacturing facilities, setting it up to grow in an area in which demand continues to outstrip supply.
Archives for May 2, 2018
WuXi Biologics says Ireland an attractive option post-Brexit, invests €325m
The Chinese CDMO says it will build a biomanufacturing facility in Ireland with single-use bioreactors and continuous bioprocessing capabilities.